ADIM
XNCR icon

Alpha DNA Investment Management’s Xencor XNCR Stock Holding History

Alpha DNA Investment Management’s Portfolio XNCR Stock Details XNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,075
Closed -$566K – 243
2023
Q3 		$566K Buy
+28,075
New +$638K 0.23% 104
2022
Q2 		– Sell
-45,178
Closed -$1.2M – 179
2022
Q1 		$1.2M Buy
+45,178
New +$1.46M 0.85% 68
2021
Q2 		– Sell
-70
Closed -$3K – 674
2021
Q1 		$3K Hold
70
– – ﹤0.01% 528
2020
Q4 		$3K Buy
+70
New +$2.9K ﹤0.01% 431

Other funds holding XNCR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Alpha DNA Investment Management's XNCR Position: Q4 2023 in Review

Alpha DNA Investment Management sold out of Xencor (XNCR) in Q4 2023, closing a stake of 28,075 shares — an estimated $566K sold.

Alpha DNA Investment Management first reported a position in XNCR in Q4 2020 and held it in 4 quarters. The position peaked at $1.2M in Q1 2022. 195 funds tracked by Wall St. Rank hold XNCR as of Q4 2023.

  • Alpha DNA Investment Management reported no remaining Xencor position as of Q4 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 28,075 Xencor shares in Q4 2023, an estimated $566K.
  • Alpha DNA Investment Management first reported a position in Xencor in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's Xencor position peaked at $1.2M in Q1 2022.
  • 195 funds tracked by Wall St. Rank held Xencor as of Q4 2023.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.